|
DDX23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.180200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.773600E-02 |
| Normal-vs-Stage2 |
4.337000E-01 |
| Normal-vs-Stage3 |
1.773320E-04 |
| Normal-vs-Stage4 |
6.989600E-04 |
| Stage1-vs-Stage2 |
2.311200E-01 |
| Stage1-vs-Stage3 |
3.718300E-02 |
| Stage1-vs-Stage4 |
1.348750E-01 |
| Stage2-vs-Stage3 |
1.501900E-02 |
| Stage2-vs-Stage4 |
4.067800E-02 |
| Stage3-vs-Stage4 |
9.250600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.437100E-03 |
| Normal-vs-AfricanAmerican |
2.703600E-01 |
| Normal-vs-Asian |
1.438380E-01 |
| Caucasian-vs-AfricanAmerican |
3.748600E-01 |
| Caucasian-vs-Asian |
3.779600E-01 |
| AfricanAmerican-vs-Asian |
8.445600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.021800E-03 |
| Normal-vs-Female |
8.659000E-03 |
| Male-vs-Female |
4.286000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.703580E-02 |
| Normal-vs-Age(41-60Yrs) |
1.078040E-02 |
| Normal-vs-Age(61-80Yrs) |
3.211500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.745530E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.741200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.236180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.340300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.276590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.839500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.190200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.798740E-03 |
| Classical-VS-Follicular |
5.268000E-02 |
| Classical-VS-Other |
4.265000E-01 |
| Classical-VS-Normal |
3.910100E-02 |
| Tall-VS-Follicular |
1.613370E-01 |
| Tall-VS-Other |
8.218000E-01 |
| Tall-VS-Normal |
2.38149999999271E-05 |
| Follicular-VS-Other |
7.607000E-01 |
| Follicular-VS-Normal |
2.020900E-03 |
| Other-VS-Normal |
2.051200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.859800E-03 |
| Normal-vs-N1 |
4.03410000004989E-06 |
| N0-vs-N1 |
5.656300E-03 |
|
|
